US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

62.22

+0.24880.40%

Post-market: 62.230.0112+0.02%19:30 EDT

Volume:17.65K

Turnover:1.10M

Market Cap:90.51M

PE:- -

High:62.82

Open:62.57

Low:62.22

Close:61.97

52wk High:68.00

52wk Low:36.13

Shares:1.45M

Float Shares:1.45M

Volume Ratio:0.34

T/O Rate:1.21%

Dividend:0.65

Dividend Rate:1.05%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

IntegraGen receives rival takeover bids amid court‑ordered restructuring

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

Moderately bullish activity in Moderna with shares up 8.03%

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live

Twist Bioscience initiated with a Sell at BWS Financial

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live

Twist Bioscience CEO, CFO to Speak at Baird Global Healthcare Conference Fireside Chat

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Moderately bullish activity in Moderna with shares down 1.79%

U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/GNOM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":62.2188,"timestamp":1789156800000,"preClose":61.97,"halted":0,"volume":17647,"hourTrading":{"tag":"盘后","latestPrice":62.23,"preClose":62.2188,"latestTime":"19:30 EDT","volume":16,"amount":996.7128,"timestamp":1789169408573,"change":0.0112,"changeRate":0.00018,"amplitude":0},"delay":0,"changeRate":0.004014845893174162,"floatShares":1454735,"shares":1454735,"eps":0,"marketStatus":"Market Closed","change":0.2488,"latestTime":"09-11 16:00:00 EDT","open":62.57,"high":62.82,"low":62.2188,"amount":1101644.7337210001,"amplitude":0.009701,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":61.97,"sharesOutstanding":1094672,"nav":62.3,"aum":93743649.5,"dividendRate":0.010458,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":64.46,"preClose":61.97,"latestTime":"09:03 EDT","volume":120,"amount":7609.2,"timestamp":1789131824178,"change":2.49,"changeRate":0.040181,"amplitude":0.020332},"postHourTrading":{"tag":"盘后","latestPrice":62.23,"preClose":62.2188,"latestTime":"19:30 EDT","volume":16,"amount":996.7128,"timestamp":1789169408573,"change":0.0112,"changeRate":0.00018,"amplitude":0},"volumeRatio":0.34164785535802483,"impliedVol":0.295,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1454735,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.34164785535802483,"shares":1454735,"dividePrice":0.6507,"high":62.82,"amplitude":0.009701,"preClose":61.97,"low":62.2188,"week52Low":36.125,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":62.2188,"eps":0,"divideRate":0.010458,"volume":17647,"delay":0,"ttmEps":0,"open":62.57,"prevYearClose":45.4562,"prevWeekClose":64.26,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":64.97,"twentyDayClose":59.0605,"sixtyDayClose":50.0103},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666508352","title":"Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666508352","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666508352?lang=en_us&edition=fundamental","pubTime":"2026-09-12 09:35","pubTimestamp":1789176943,"startTime":"0","endTime":"0","summary":"Natera Executive Chairman Matthew Rabinowitz disposes of USD 16.32 million in common sharesNatera Executive Chairman Matthew Rabinowitz sold 50,000 common shares on Sept. 11, 2026 at about USD 325.01 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260912:nNDL6qGymP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","LU0012050646.USD","BK4139","LU2065171311.SGD","LU1988902786.USD","LU2065170008.USD","LU2065169927.USD","LU2065171402.SGD","LU0963586101.USD","LU2264538146.SGD","LU2324357040.USD","LU2065731478.USD","LU0345770993.USD","GNOM","LU0053671581.USD","LU0106261612.USD","LU0345770308.USD","NTRA","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","TMED","BK4568","LU0965509010.AUD","LGHT","IE00BKVL7J92.USD","BK4548","LU0965508806.USD","LU1674673428.USD","BIB","IDNA","BMED","WDNA","LU1934455277.USD","LU0058720904.USD","IBB","SG9999015986.USD","LU1571399168.USD","SG9999015978.USD","MRNX","MRNA","LU0289739699.SGD","LU1066051498.USD","LU0965509283.SGD","GNOM","IE00BSNM7G36.USD","LU1674673691.USD","BK4534","LU2468319806.SGD","IBBQ","MEDI","TBXU","BK4578","GILD","IE00B3T34201.USD","LU0114720955.EUR","LU0965509101.SGD","LU1057294990.SGD","LU0861579265.USD","LU1585245621.USD","BBH","LU0109394709.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU0889565916.HKD","LU1430594728.SGD","LU2357627491.SGD","BK4588","LU1778281490.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666579410","title":"IntegraGen receives rival takeover bids amid court‑ordered restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2666579410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666579410?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:02","pubTimestamp":1789153348,"startTime":"0","endTime":"0","summary":"IntegraGen SA ( ($FR:ALINT) ) has provided an update. IntegraGen SA, a French genomics company focused on cancer and rare genetic diseases, provide...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","DARP","FWD","GNMX","TARK","IDNA","GNOM","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666575576","title":"Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666575576","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666575576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:15","pubTimestamp":1789146928,"startTime":"0","endTime":"0","summary":"• Moderna experienced upward volatility driven by renewed institutional buying and consolidation.\n• Phase 3 trial results for intismeran autogene validated its oncology platform.\n• Latest annual revenue is $1.94B with a net loss of $-2.82B.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262164027-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","GNOM","BK4568","BK4533","BK4534","MRNY","BK4551","WDNA","BK4139","MRNA","LGHT","IDNA","MRNX","BK4532","BK4585","BK4588","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666576334","title":"Moderately bullish activity in Moderna with shares up 8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666576334","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666576334?lang=en_us&edition=fundamental","pubTime":"2026-09-12 01:00","pubTimestamp":1789146015,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares up $10.97, or 8.03%, near $147.59. Options volume roughly in line with average with 139k...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-up-8-03-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LGHT","MRNX","MRNY","GNOM","BK4551","BK4548","BK4533","IDNA","BK4532","BK4568","MRNA","BK4139","WDNA","BK4501","BK4534","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666573009","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2666573009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666573009?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:00","pubTimestamp":1789142409,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeDell Technologies IncDELL.N+11.0%Hewlett Packard Enterprise CompanyHPE.N+9.1%Skyworks Solutions, Inc.SWKS.OQ+8.1%Moderna, Inc.MRNA.OQ+8.1%Flex LtdFLEX.OQ+7.8%Bottom PerformersPercent ChangeSeagate Technology Holdings PLCSTX.OQ-3.6%Baker Hughes CompanyBKR.OQ-3.1%SanDisk CorporationSNDK.OQ-3.1%The Clorox CompanyCLX.N-2.9%Palo Alto Networks, Inc.PANW.OQ-2.6%As of 12:00 p.m., the S&P 500.SPXgained 78.63 points, or 1.04%, to 7,670.33 and had posted 7 new 52-week highs and 6 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL8N4531EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","BK4550","LU1983260115.SGD","LU2265009873.SGD","SPHQ","PALU","LU1861220033.SGD","LU1989764664.SGD","ITOT","SPYQ","BK4554","IE00BN0W2T93.GBP","LU1670627923.USD","LU0175139822.USD","LU2210149790.SGD","LU2210150020.SGD","SPUS","LU0128525689.USD","LU0823434740.USD","BKR","SPXL","FCUS","SNXX","WCBR","BK4145","IGV","LU0081259029.USD","MRNA","SCHB","CNAV","LU1992135399.USD","LU1823568750.SGD","EGGY","ETFT","IE00B894F039.SGD","IJH","BK4515","VEU","LU2290526834.HKD","SPHD","SPYH","BUG","BK4581","LU0154245756.USD","LU0289739343.SGD","LU2065170008.USD","WCLD","BK4139","HPE","PANW","LU0256331488.USD","RSPU","HPEL","SPYD","SNDK","LU0511384066.AUD","LU2286300806.USD","IE00B19Z8W00.USD","LU1720051108.HKD","IDNA","LU1917777945.USD","LU0251142724.SGD","BK4179","SMAX","LU0321505439.SGD","LU2322448791.USD","BK4598","DRMY","NOBL","SPGP","LU1366192091.USD","LU0006061336.USD","LU2272731865.HKD","JEPI","BK4560",".SPX","BK4141","LU0052756011.USD","LU0057025933.USD","LU2272731782.SGD","LU2244417387.USD","RSPA","BK4566","IEZ","LU0348723411.USD","LU1235294995.USD","LU2106854487.HKD","IE00B19Z9505.USD","LU2322448957.HKD","QQQG","HIBL","LU1169590202.USD","BK4567","IJR","TMSL","LU0048573561.USD","BK4585","BK4504","BK4548","DBSC","LU1989764748.USD","LU2125909916.SGD","LU1261432733.SGD","VV","BK4535","IVE","VOOG","DMAX","FXL","GPIX","MRNX","RULE","LU0070302665.USD","LU1992135472.HKD","LU0208291251.USD","BK4551","OIH","PALD","LU0289961442.SGD","GSLC","BK4605","LU0203345920.USD","SFY","VOO","LU0345770993.USD","LU2023250843.SGD","SPYU","PTF","CLX","CIBR","DISK","LU1923622291.USD","BK4512","LU1974910355.USD","LU2543165471.USD","SH","STXL","LU1267930227.SGD","SNDG","IE00BZ1G4Q59.USD","GNOM","SCHA","SPLV","BMAY","SSO","LU2065171311.SGD","LU2357305700.SGD","LU2065171402.SGD","SCHM","LU0823434583.USD","PSWD","VTI","STXU","LU0082616367.USD","LU0187121727.USD","UPRO","LU1712237335.SGD","BK4097","LU0306806265.USD","LU1084165304.USD","LU1046421795.USD","LU1169589451.USD","XDTE","LU0069063385.USD","BK4533","LU0124676726.USD","LU1623119135.USD","SPY","LU0742534661.SGD","PXJ","LU0823421333.USD","SPXU","VBK","LU1720051017.SGD","BK4018","LU1119994496.HKD","MMAX","VTV","BK4532","LU0496365809.HKD","BK4170","LGHT","BK4543","LU0234570918.USD","CLOD","LU0345770308.USD","SPYV","LU0689626769.HKD","BK4534","LU0225771236.USD","LU2272731600.USD","MRNY","STXX","LU0963586101.USD","MOAT","IE00B19Z3B42.SGD","SPYM","LU1548497426.USD","SPYG","LU1804176565.USD","SCHX","LU1670628061.USD","FLEX","LU2360107168.USD","IE00BN0W2W23.USD","FLEL","LU0306807586.USD","HIBS","LU2098885051.SGD","IE00B7SZLL34.SGD","IE00BMPRXR70.SGD","LU2023250504.SGD","RSPN","ALLW","LU0320765489.SGD","OPTZ","SPAM","LU0225284248.USD","LU2355687059.USD","YSPY","SNDC","XYLD","BK4501","WLDR","LU1153585028.USD","LU0211331839.USD","LU2063271972.USD","QQQA","IVW","LU0985481810.HKD","LU0289960550.SGD","STX","PANG","LU2473716301.USD","XLG","LU0267386448.USD","LU0154245673.USD","SNDQ","IE0002270589.USD","SPMO","IE00B19Z8X17.USD","AIFD","HAKY","IE00B19Z3581.USD","IE00BMPRXN33.USD","IVV","LU0054578231.USD","LU0266013472.USD","LU0203347892.USD","LU0211326755.USD","LU0472753341.HKD","RSP","IE00B19Z9P08.USD","IE00BKVL7J92.USD","LU0719512351.SGD","SG9999001424.SGD","SPDN","ACWI","IE00B19Z9Z06.USD","TSPY","LU0823421416.USD","IE00BN0W2V16.EUR","WDNA","BK4568","DELL","DLLL","IHAK","LU0211326839.USD","LU0321505868.SGD","LU2065169927.USD","LU2095319765.USD","COWG","BK4588","SDS","SWKS","LU0011850046.USD","LU1861215975.USD","LU0310800965.SGD","SPXS","LU0251131958.USD","FSMD","LU1571399168.USD","LU2125909759.SGD","SNDU","LU0976567544.SGD","SPUU","LU1303367103.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529289","title":"Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529289","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529289?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:22","pubTimestamp":1789125772,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $112.72, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4568","BK4585","BK4532","BK4588","GNOM","MRNY","IDNA","BK4551","WDNA","MRNA","BK4501","BK4548","MRNX","LGHT","BK4534","BK4533","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666422435","title":"Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666422435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666422435?lang=en_us&edition=fundamental","pubTime":"2026-09-11 16:20","pubTimestamp":1789114812,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Moderna (MRNA), Merck & Company (MRK) and Pacific ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moderna-mrna-merck-company-mrk-and-pacific-biosciences-pacb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","PACB","MRK","LU2361044865.SGD","LU0130102774.USD","IE00BN8TJ469.HKD","LU2125909593.SGD","IE00BLSP4452.SGD","LU1941712348.USD","JDOC","LU1037948897.HKD","LU0058720904.USD","LU1066053197.SGD","LU0098860793.USD","IE000M9KFDE8.USD","MRNY","LU2125154935.USD","LU1989772923.USD","LU2089984988.USD","LU0861579265.USD","PPH","LU0106261372.USD","LU1066051811.HKD","LU2112291526.USD","BK4533","LU0124676726.USD","BK4588","LU1093756168.USD","LU0689626769.HKD","LU1037948541.HKD","LU0238689110.USD","LU0320765646.SGD","IE0002141913.USD","LU1974910355.USD","LU1934455863.HKD","BK4516","LU0006306889.USD","IE00B4R5TH58.HKD","LU1201861249.SGD","LU0823416689.USD","SG9999002232.USD","LU2023250843.SGD","SG9999014575.USD","IE00B2B36J28.USD","LU1023059063.AUD","MRNX","LU0965509283.SGD","SG9999001440.SGD","LU0211331839.USD","LGHT","LU0234572021.USD","IE00BSNM7G36.USD","SG9999014559.SGD","FHLC","LU1116320737.USD","LU1066051498.USD","LU1057294990.SGD","BK4585","LU0203345920.USD","FTXH","LU0965509101.SGD","LU1430594728.SGD","LU0942090050.USD","BK4548","HRTS","LU0265550946.USD","LU1093756325.SGD","LU2461242641.AUD","SG9999014567.USD","LU2491050071.SGD","BMED","LU1032466523.USD","LU2125154778.USD","LU1934455194.USD","LU0985320562.USD","IDNA","LU0859254822.USD","LU2468319806.SGD","LU0070302665.USD","IE00BBT3K403.USD","LU0265550359.USD","LU1061106388.HKD","MRNA","BK4007","IHE","LU1035773651.USD","LU0208291251.USD","LU2361044949.HKD","LU2361045086.USD","LU1699723380.USD","LU2324357040.USD","WDNA","LU2360032135.SGD","SG9999001176.SGD","PAWZ","LU1571399168.USD","VHT","LU1066051225.USD","LU1917777945.USD","LU0965508806.USD","LU1923622614.USD","LU1989771016.USD","SG9999001176.USD","BK4559","BK4550","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","BK4139","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2491050154.USD","IXJ","LU0122379950.USD","SG9999014542.SGD","IE0009355771.USD","TRUH","LU0203347892.USD","LU0477156953.USD","RXL","GDOC","LU0266013472.USD","LU1116320901.HKD","LU1989772840.SGD","LU1585245621.USD","LU2433249047.HKD","SGXZ57979304.SGD","GNOM","LU1929549753.HKD","LU1934455277.USD","SG9999015358.SGD","BK4551","LU0130517989.USD","BK4121","LU1941712264.USD","BK4568","LU0432979614.USD","BK4501","SG9999015341.SGD","LU0648001328.SGD","LU2125909247.SGD","SG9999002224.SGD","BK4534","LU2491049909.HKD","SG9999013999.USD","LU0320765489.SGD","BK4532","LU0965509010.AUD","LU1983299246.USD","LU2023250504.SGD","LU2106854487.HKD","LU1069347547.HKD","LU2357627491.SGD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","LU1162221912.USD","LU0980610538.SGD","LU1291159041.SGD","LU0868494708.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666601548","title":"Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666601548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666601548?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:30","pubTimestamp":1789097407,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Expeditors International (EXPD) and Illumina (ILMN). Exped...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-expeditors-international-expd-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-expeditors-international-expd-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","LU2506951958.HKD","LU0950375773.USD","LU0128526141.USD","BK4567","BK4585","BK4534","EXPD","BK4533","LU0029874061.USD","BK4141","BK4121","LU0823417737.USD","BK4548","BK4535","NA","LU2506951875.HKD","LU2506952097.USD","GNOM","HULL","LU0823417653.USD","BK4131","ILMN","BK4588","LU2506952170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581105","title":"Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581105","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666581105?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:45","pubTimestamp":1788990300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TWST/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","TWST","BK4139","GNOM","IDNA","BK4585","WDNA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311265","title":"Moderna Set for 3 Near-Term INT Data Readouts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311265","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311265?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969505,"startTime":"0","endTime":"0","summary":"Moderna  is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Securities said in a Tuesday note.The next major catalyst is the release of phase 3 data on melanoma at an international conference this fall, investors awaiting efficacy on recurrence-free survival and distant metastasis-free survival, the brokerage said.Likely to follow is the phase 2 data on either renal cell carcinoma or muscle-invasive bladder cancer, potentially in 2027, according to UBS. The next readout is probably a phase 3 update on adjuvant non-small cell lung cancer, the investment firm added.UBS has a neutral rating and $150 price target on Moderna.Price: 137.50, Change: -2.83, Percent Change: -2.02","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4501","MRNY","BK4551","LGHT","MRNX","BK4532","BK4533","BK4139","BK4568","BK4548","GNOM","IDNA","BK4585","MRNA","BK4534","BK4588","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368655","title":"UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368655","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960920,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $198.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EKG","BK4585","LFSC","GNMX","LU0320765992.SGD","PTH","HELX","GH","LU0109394709.USD","BK4196","GNOM","GDOC","BK4535","BK4588","LU0889565916.HKD","FFOX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536557","title":"Twist Bioscience initiated with a Sell at BWS Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536557?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:30","pubTimestamp":1788960619,"startTime":"0","endTime":"0","summary":"BWS Financial initiated coverage of Twist Bioscience (TWST) with a Sell rating and $45 price target Twist’s stock surge in August, driven by Anthro...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/twist-bioscience-initiated-with-a-sell-at-bws-financial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/twist-bioscience-initiated-with-a-sell-at-bws-financial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TWST","BK4585","BK4139","GNOM","WDNA","BK4588","IDNA","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538213","title":"UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538213","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538213?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:17","pubTimestamp":1788956271,"startTime":"0","endTime":"0","summary":"Twist Bioscience (TWST) has an average rating of buy and mean price target of $87.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ba","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TWST","WDNA","ARKG","BK4139","BK4585","IDNA","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538631","title":"Twist Bioscience CEO, CFO to Speak at Baird Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538631","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538631?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955397,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO, CFO to speak at Baird Global Healthcare Conference fireside chatTwist Bioscience will join the Baird 2026 Global Healthcare Conference in New York City on Sept. 15, 2026.CEO Emil","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL63nZ4z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TWST","WDNA","BK4139","BK4585","GNOM","ARKG","IDNA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APXH","BME","IBRN","GNOM","SBIO","IBBQ","GPCR","IBBJ","IBB","RSPH","XPH","CURE","MEDI","SURI","GNMX","JDOC","BBH","FHLC","MDTX","MEDX","BIB","MNTL","SYNB","PBE","PJP","JHMH","LFSC","FBT","PSCH","PTH","HYLG","LLYX","GDOC","WDNA","NVIB","MRNY","PSIL","HRTS","PBPH","TBXU","PINK","FTXH","CANC","IEIH","GSKH","CNCR","FXH","AZNH","IDNA","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372326","title":"Moderately bullish activity in Moderna with shares down 1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:20","pubTimestamp":1788891611,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Moderna (MRNA), with shares down $2.60 near $142.95. Options volume relatively light with 44k contracts traded and c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-moderna-with-shares-down-1-79-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4548","IDNA","LGHT","BK4139","MRNA","BK4532","BK4551","WDNA","BK4534","BK4568","GNOM","BK4533","BK4585","MRNY","BK4501","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665752763","title":"U.S. Stocks on the MOVE-Sigma Lithium, Shake Shack, Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2665752763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665752763?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:57","pubTimestamp":1788875845,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Sigma Lithium, Shake Shack, NovartisSeptember 8 (Reuters)-Wall Street's main indexes were mixed at open on Tuesday as fresh hostilities in the Middle East pushed oil price","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL6N4500HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEX","BK4182","PUL","LU0238689110.USD","IONS","UPGR","IE0009355771.USD","LU1489326972.SGD","BHVN","MEDX","LU0823414478.USD","EGGY","HYDR","RGTC","BK4567","BK4121","AMGN","IE00B66KJ199.SGD","LU1720051017.SGD","BK4139","LU2242646821.SGD","RGYY","LU2491049909.HKD","IE00B2B36J28.USD","LU0251132253.USD","LU2543165471.USD","IE00B19Z4B17.USD","LU1571399168.USD","SEI","LU0029874061.USD","LU1861559042.SGD","SGXZ57979304.SGD","WQTM","IE00B7SZL793.SGD","LU2506952170.USD","FRNW","LU0266013472.USD","IONC","BK4082","LU0957808578.USD","BK4588","LU0289739699.SGD","LU1815336760.USD","BK4170","LU1366192091.USD","LU2362541273.HKD","LU1642822529.SGD","LU2506952097.USD","NVS","LU0950375773.USD","IONX","PJP","SG9999001176.SGD","ALV","IONQ","LU0345769128.USD","LU1023059063.AUD","LU1720051108.HKD","LU1983299246.USD","LU2324357040.USD","BK4504","BIB","IE00BJT1NW94.SGD","BSX","BEG","LU0528227936.USD","BK4535","CQTM","LU1989772840.SGD","IE00BFTCPJ56.SGD","BK4007","LU1057294990.SGD","LU0154245756.USD","LU0109394709.USD","LU0070302665.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0208291251.USD","BEZ","LU0128526141.USD","LU0211331839.USD","LU1093756168.USD","LU1804176565.USD","RGTU","WATS","04332","LU0068578508.USD","BK4168","BK4124","BK4532","BK4209","LU0432979614.USD","LU2244417387.USD","NTLA","BK4591","LU0823417737.USD","IONL","SRPU","TBXU","LU0187121727.USD","LU0138981039.USD","LU2468319806.SGD","LU1548497426.USD","LU0267386448.USD","LU2491050154.USD","LU1064131342.USD","IBBQ","ICLN","LU0868494617.USD","LU2491050071.SGD","IE0031619046.USD","BK4581","LU0345769631.USD","BK4578","SHAK","IOYY","PHVS","LU2249611893.SGD","SG9999001176.USD","USNG","BK4602","IE0034235188.USD","CNRG","BK4556","BK4533","DYN","BK4599","LU1989764664.SGD","BK4131","LU2089984988.USD","LU1061106388.HKD","RGTZ","SRPT","UNFI","LU0154245673.USD","LU2506951958.HKD","LU2087625088.SGD","LU2294711713.HKD","LU0823416689.USD","BK4585","RGTI","LU0122379950.USD","LU2265009873.SGD","LU0114720955.EUR","ROIV","BK4566","IBAT","BK4102","IE00B4R5TH58.HKD","PBE","VCLN","SMOG","BK4120","SGML","IE0009354923.USD","LU1303367103.USD","LU2098885051.SGD","LU1153585028.USD","BK4548","GNOM","GNMX","LU1989772923.USD","LU0353189763.USD","BEC","LU2242649171.HKD","SIMS","LU1878469433.USD","LU0433182093.SGD","BK4505","P","LU1861558580.USD","OIH","BK4534","IE0002141913.USD","LU1791710400.SGD","LU2357125470.USD","QTUP","LU0048584097.USD","ZAP","LU0823414551.USD","LU0058720904.USD","VTWG","LU1988902786.USD","LU0823417653.USD","LU2242652126.USD","SG9999001440.SGD","IONZ","LU1989771016.USD","LU0444971666.USD","BK4597","LU0878866978.SGD","LU0077335932.USD","LU0444973449.USD","LU2357305700.SGD","RGTX","LU2264538146.SGD","BK4141","LU2362540622.SGD","LU1718418525.SGD","LU2112291526.USD","LU0320765489.SGD","LU0985489474.SGD","LU0353189680.USD","BK4179","LU0225283273.USD","LU0320765992.SGD","CTEC","SG9999013999.USD","LU0882574055.USD","PTH","ILMN","LU2506951875.HKD","ABM","LU1791710582.SGD","LU0476273544.USD","LU1989764748.USD","LU0011850046.USD","LU2362541513.USD","LU2506951792.HKD","LU1291159041.SGD","CHRW","PPH","BE","BK4541","XES","IBB","LU1093756325.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665373511","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665373511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665373511?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:51","pubTimestamp":1788871865,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN), Guardant Health (GH) and Neurocrine (N...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-guardant-health-gh-and-neurocrine-nbix-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","GNMX","PTH","IE00BFTCPJ56.SGD","LU0154245756.USD","LU2065170008.USD","FFOX","GNOM","PJP","BK4137","LU2242646821.SGD","NBIX","BK4585","XBI","LU0029874061.USD","GH","BBH","GDOC","LU2242652126.USD","LFSC","BK4535","LU0889565916.HKD","HELX","PBE","IBB","LU1057294990.SGD","BK4588","IBBQ","LU0154245673.USD","BK4534","TBXU","IE0009355771.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","XLV","LU0109394709.USD","AMGN","IE0002141913.USD","LU0823416689.USD","BIB","LU0058720904.USD","BK4139","BK4533","LABU","LU0289739699.SGD","IE00B2B36J28.USD","BK4599","LU2468319806.SGD","EKG","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTXH","JHMH","WDNA","MRNY","PJP","XPH","CNCR","IDNA","LENZ","LFSC","JDOC","TBXU","BBH","MNTL","GNOM","PBPH","IBB","PSIL","PBE","GNMX","MEDI","GDOC","FXH","IBBJ","FBT","LLYX","GPCR","MDTX","PINK","MEDX","GSKH","APXH","NVIB","CANC","BBP","SBIO","PSCH","BME","CURE","SURI","RSPH","HYLG","IBBQ","PTH","AZNH","FHLC","BIB","SYNB","HRTS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}